Community/Retail

Monthly treatment with evolocumab reduced LDL-C by a mean of 38% from baseline compared to placebo among patients ages 10 to 17 with heterozygous familial hypercholesterolemia.

Investigators at Stanford Medicine find that 72% of individuals who took the highest dose of ON-SXB were considered much or very much improved.

Policy makers should consider structural incentives to improve generic drug access, investigators say.

A new study examined 3 different cases of chronic urticaria being treated with cyclosporine and patients who developed reactivation of recurrent herpes zoster (HZ) following COVID-19 vaccination.

Shawn Singh, CEO of VistaGen, discusses how to improve and more effectively treat mental health disorders for returning veterans, who currently account for 20% of all suicides in the United States.

Laura Lee Hall, PhD, president of the Center for Sustainable Health Care Quality and Equity (SHC), discusses the SHC’s recently released Flu DRIVE Toolkit, which was designed to help overburdened health systems improve flu vaccination rates among vulnerable populations.

Because Biktarvy is a complete regimen, coadministration with other antiretroviral medications for the treatment of HIV-1 infection is not recommended.

Ulcerative colitis and Crohn disease are the two main forms of inflammatory bowel disease.

Pharmacists can assess patients' needs, evaluate what is required for specific destinations, and provide relevant resources.

A panel of experts in the field of ketamine therapy discuss the role of the pharmacist in this field and the future of ketamine and assisted therapies based on current medical research.

This month's featured products include empagliflozin, finerenone, and more.

Although frontotemporal dementia is the leading cause of the disease for those under 65 years of age, far fewer people are familiar with it than with Alzheimer disease.

Menopause can happen in your 40s or 50s, but the average age is 51 years in the United States.

Digital health tools improve patient outcomes while expanding career opportunities for pharmacists.

A shortage of pharmacists led to a call for pharmacy education in Alaska that echoed across the state.

This month's featured products include an infants' pain and fever reducer, daily supplements for nerve care and pain, and more.

The COVID-19 booster doses are to be administered at least 6 months after completion of the primary 2-dose series and are the same formulation and dosage strength as the original doses.

Remdesivir demonstrated a statistically significant 87% reduction in risk for the composite primary endpoint of COVID-19-related hospitalization or all-cause death by day 28.

Ten quiz questions to assess your knowledge on common symptoms and treatments for genital herpes.

Crizanlizumab is a humanized IgG2 kappa monoclonal antibody that binds to P-selectin and blocks interactions with its ligands.

DEA seizure of large-scale narcotics points to potential drug diversion in supply chain.

Ideas for potential new services are often plentiful, but these ideas must be carefully evaluated in order to select the right one and see it to fruition.

In part 2 of their discussion on COVID-19 vaccine mandates, experts Ned Milenkovich, PharmD, and Ron Lanton III, Esq., discussed how provider status could impact potential legal issues around COVID-19 vaccine mandates.

Doctors and pharmacists discuss OTC and prescription treatment options and use during webcast.

In clinical trials, the majority of patients with atopic dermatitis treated with ruxolitinib had clear or almost clear skin.

Thomas Menighan, co-founder of PursueCare and the CEO Emeritus of the American Pharmacists Association, discusses a pharmacists role in National Recovery Month.

Verquvo is a soluble guanylate cyclase stimulator indicated to reduce the risk of cardiovascular death and heart failure.

COVID-19 may change how stress for women in the pharmacy profession is viewed.